Tools

Driven by improvements in living standards, the rising incidence of diabetes in BRIC is expected to amount to a staggering… »   

Amid calls to pull the controversial diabetes drug Avandia from the market, new research suggests that a low dose of… »   

DIAGNOS inc. (“DIAGNOS” or “the Corporation”) /quotes/comstock/11v!e:adk (CA:ADK 0.42, -0.03, -5.62%) , a leader in the use of artificial intelligence… »   

U.S. health regulators have finalized new warnings for controversial inhaled asthma drugs.

The warnings, expected since February, say medicines… »   

Italy is taking new steps to rein in healthcare spending and reduce the country’s drugs bill by imposing a cut… »   

Three new oral blood-thinning drugs nearing approval by the Food and Drug Administration are more convenient than the standard… »   

The French government will cut healthcare spending by an extra 600 million euros ($735 million) this year, including reducing drug… »   

GlaxoSmithKline Plc has settled thousands more lawsuits brought by patients alleging its Avandia diabetes drug caused heart attacks, in… »   

A 12-year-old Australian girl and her mother are the first people to try an experimental treatment for a deadly… »   

This month’s Ophthalmology, the journal of the American Academy of Ophthalmology, includes new studies on links between eye diseases and… »